| Trial ID: | L4089 |
| Source ID: | NCT02312063
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
|
| Acronym: |
DIET
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02312063/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Glimepiride
|
| Outcome Measures: |
Primary: Correlation of Plasma Levels of EPA and DHA With HbA1c Reduction, Pearson's correlation coefficient of HbA1c reduction with plasma levels of EPA and DHA at baseline, 0-16 weeks | Secondary: Correlation of Estimated Seafood Intake With HbA1c Reduction, Pearson's correlation coefficient of HbA1c reduction with estimated seafood intake, 0-16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Kansai Electric Power Hospital | Collaborators: Saiseikai Noe Hospital Osaka
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-02
|
| Completion Date: |
2016-05
|
| Results First Posted: |
2019-07-01
|
| Last Update Posted: |
2019-07-01
|
| Locations: |
Saiseikai Noe Hospital Osaka, Osaka, 536-0001, Japan|Kansai Electric Power Hospital, Osaka, 553-0003, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT02312063
|
